| Not Yet Recruiting | Safety and Preliminary Efficacy of HN2302 in Patients With Autoimmune Diseases NCT07523282 | Shenzhen MagicRNA Biotechnology Co., Ltd | Phase 1 |
| Recruiting | A Study of Safety, Tolerability, PK, and PD of Subcutaneous GenSci136 in Healthy Adults. NCT07366866 | Changchun GeneScience Pharmaceutical Co., Ltd. | Phase 1 |
| Recruiting | Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals NCT06817889 | Fred Hutchinson Cancer Center | Phase 2 |
| Recruiting | Safety and Efficacy of CD19 CAR-T Therapy for Recurrent/Refractory Autoimmune Diseases NCT06983964 | Beijing Boren Hospital | N/A |
| Recruiting | Autologous CD19CAR-T Therapy for Recurrent/Refractory Autoimmune Diseases NCT06993493 | Beijing Boren Hospital | N/A |
| Completed | A Study of Safety, Tolerability, PK, and PD of Subcutaneous GenSci120 in Healthy Adults. NCT06827457 | Changchun GeneScience Pharmaceutical Co., Ltd. | Phase 1 |
| Not Yet Recruiting | The Safety and Efficacy of Universal CAR-T Cells Targeting BCMA in the Treatment of Refractory NMOSD NCT06633042 | Bioray Laboratories | Phase 1 |
| Unknown | Evaluate the Safety and Tolerability of SCT650C in Healthy Volunteers NCT05894707 | Sinocelltech Ltd. | Phase 1 |
| Completed | Single and Multiple Ascending Dose Study in Healthy Participants and Participants With an Autoimmune Disease NCT06488209 | Almirall, S.A. | Phase 1 |
| Recruiting | Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidat NCT04751396 | M.D. Anderson Cancer Center | — |
| Recruiting | Autoimmune and Autoinflammatory Genetics Study NCT06004349 | NYU Langone Health | — |
| Recruiting | Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorde NCT03816345 | National Cancer Institute (NCI) | Phase 1 |
| Unknown | Leflunomide Treatment for IgG4-RD NCT03715699 | Peking Union Medical College Hospital | N/A |
| Terminated | Aerobic Exercise in Women With Systemic Lupus Erythematosus NCT03186794 | National Institutes of Health Clinical Center (CC) | N/A |
| Withdrawn | Regulation of LncRNA For Breg in Patients With Thymoma and Autoimmune Diseases NCT02948855 | Tianjin Medical University Cancer Institute and Hospital | — |
| Completed | Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis NCT02647866 | Kyowa Kirin, Inc. | Phase 2 |
| Completed | Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory Diseases NCT02925351 | Jonsson Comprehensive Cancer Center | EARLY_Phase 1 |
| Completed | Sudoscan in Patients With Autoimmune Disorders NCT02434458 | The Catholic University of Korea | — |
| Unknown | Study of Treatment Response on IgG4 Related Disease (IgG4RD) NCT02458196 | Peking Union Medical College Hospital | Phase 2 |
| Completed | A Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of TAK-079 in Healthy Participants NCT02219256 | Takeda | Phase 1 |
| Unknown | Identification of Correlations Between Reaction to Biotine and Autoimmune Diseases NCT01934764 | Ziv Hospital | — |
| Completed | Pancreatic Duct Evaluation in Autoimmune Pancreatitis: MR Pancreatography NCT01773031 | Jae Ho Byun | — |
| Completed | Identify Clinical Conditions That Increase Circulating DNA Levels NCT01815996 | University of Florida | — |
| Unknown | 18F-FDG PET/CT for IgG4-Related Disease NCT01665196 | Peking Union Medical College Hospital | EARLY_Phase 1 |
| Terminated | On Open-Label Study in Participants With Systemic Lupus Erythematosus NCT01488708 | Eli Lilly and Company | Phase 3 |
| Recruiting | The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing NCT01280825 | University of Chicago | — |
| Completed | A Study of LY2127399 in Participants With Systemic Lupus Erythematosus NCT01205438 | Eli Lilly and Company | Phase 3 |
| Completed | Intravenous Immunoglobulin for PANDAS NCT01281969 | National Institute of Mental Health (NIMH) | Phase 3 |
| Recruiting | Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy NCT00977977 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 2 |
| Completed | A Study of LY2127399 in Participants With Systemic Lupus Erythematosus NCT01196091 | Eli Lilly and Company | Phase 3 |
| Completed | Rituximab for Autoimmune Retinopathy NCT01086631 | National Eye Institute (NEI) | Phase 1 |
| Completed | Screening Protocol for Subjects Being Evaluated for Center for Human Immunology, Autoimmunity, and Inflammator NCT00968084 | National Heart, Lung, and Blood Institute (NHLBI) | — |
| Recruiting | Natural History of Bronchiectasis NCT00943514 | National Heart, Lung, and Blood Institute (NHLBI) | — |
| Active Not Recruiting | Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases NCT00716066 | Fred Hutchinson Cancer Center | Phase 2 |
| Completed | The Use of Anti-CD4 Monoclonal Antibody (mAb)-Fragment for the Imaging of Chronic Inflammation in Patients Wit NCT00372177 | Biotectid GmbH | Phase 1 / Phase 2 |
| Completed | Immunogenicity of HPV Vaccine in Immunosuppressed Children NCT02263703 | The University of New South Wales | Phase 3 |
| Completed | Gastrointestinal and Health-related Quality of Life Outcomes in Patients With Autoimmune Diseases Treated With NCT00351377 | Novartis Pharmaceuticals | Phase 3 |
| Completed | Scleroderma: Cyclophosphamide or Transplantation NCT00114530 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 / Phase 3 |
| Completed | Pyrimethamine to Treat Autoimmune Lymphoproliferative Syndrome NCT00065390 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Completed | Confirmation of Systemic Autoimmune Diseases in the Agricultural Health Study NCT00341198 | National Institute of Environmental Health Sciences (NIEHS) | — |
| Completed | Pyrimethamine and Sulfadoxine for Treatment of Autoimmune Lymphoproliferative Syndrome NCT00013689 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Completed | Continuation of Follow-up of DES-Exposed Cohorts NCT00340600 | National Cancer Institute (NCI) | — |
| Completed | Treatment of Autoimmune Thrombocytopenia (AITP) NCT00001630 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 1 |
| Completed | Amoxicillin for the Treatment of Pediatric Autoimmune Disorders Associated With Streptococcal Infections NCT00001658 | National Institute of Mental Health (NIMH) | Phase 4 |
| Completed | Steroid Therapy in Autoimmune Premature Ovarian Failure NCT00001306 | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | — |